Effect of calcitonin in frozen shoulder treatment
Phase 3
Recruiting
- Conditions
- Frozen shoulder.Adhesive capsulitis of unspecified shoulderM75.00
- Registration Number
- IRCT20220523054971N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Patients with a clinical diagnosis of frozen shoulder
Patients symptoms including limitation in all active and passive movements of the shoulder joint in all directions
Patients with relatively severe pain
Patients with reduction in the range of motion of the shoulder
Definite confirmation of the diagnosis with the help of MRI of the shoulder joint
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain changes with visual analogue scale(VAS). Timepoint: 6 weeks after receiving calcitonin nasal spray. Method of measurement: Visual analogue scale.;Changes in the range of motion with the angle scale in degrees. Timepoint: 6 weeks after receiving calcitonin nasal spray. Method of measurement: Degrees of angle.
- Secondary Outcome Measures
Name Time Method